# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001224
Filing Date
2025-05-13
Accepted
2025-05-13 16:01:39
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | atxs-20250331x10q.htm iXBRL | 10-Q | 1186879
2 | EX-31.1 | atxs-20250331xex31d1.htm | EX-31.1 | 12071
3 | EX-31.2 | atxs-20250331xex31d2.htm | EX-31.2 | 12049
4 | EX-32.1 | atxs-20250331xex32d1.htm | EX-32.1 | 7617
| Complete submission text file | 0001410578-25-001224.txt |  | 5859638

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | atxs-20250331.xsd | EX-101.SCH | 40083
6 | EX-101.CAL | atxs-20250331_cal.xml | EX-101.CAL | 40298
7 | EX-101.DEF | atxs-20250331_def.xml | EX-101.DEF | 172917
8 | EX-101.LAB | atxs-20250331_lab.xml | EX-101.LAB | 380092
9 | EX-101.PRE | atxs-20250331_pre.xml | EX-101.PRE | 271990
70 | EXTRACTED XBRL INSTANCE DOCUMENT | atxs-20250331x10q_htm.xml | XML | 1019276

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 25939817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)